Intranasal oxytocin pilot study investigates feasibility for methamphetamine withdrawal in women
Intranasal Oxytocin for Methamphetamine Withdrawal in Women
Abstract
A pilot study will assess the feasibility and safety of intranasal oxytocin to improve withdrawal outcomes in women with methamphetamine use disorder.